Search results
Results from the WOW.Com Content Network
Ian Gibbons (March 6, 1946 – May 23, 2013) was a British biochemist and molecular biology researcher who served as the chief scientist of the American company Theranos, which was founded by Elizabeth Holmes.
Balwani, 57, faces a dozen wire fraud and conspiracy charges tied to his role as an executive in Theranos, which imploded after it became clear that its blood-testing technology did not work as ...
The other charges of fraud against Theranos include claiming the company's technology was being used by the U.S. Department of Defense in combat situations. [24] Another false claim included claiming a $100 million revenue stream in 2014 that was actually $100,000. [25] Balwani departed from his position at Theranos in May 2016.
On June 15, 2018, following an investigation by the U.S. Attorney's Office for the Northern District of California in San Francisco that lasted more than two years, a federal grand jury indicted Holmes and former Theranos chief operating officer and president, Ramesh "Sunny" Balwani, on nine counts of wire fraud and two counts of conspiracy to commit wire fraud.
Theranos founder Elizabeth Holmes (center) arrives to attend her fraud trial at federal court in San Jose, California, U.S. January 3, 2022. REUTERS/Brittany Hosea-Small (Brittany Hosea-Small ...
She founded DotLab in 2016, a year after a scathing WSJ report exposed Elizabeth Holmes’ Theranos. “The scientific bar, the technological bar was raised because of the fraud that looks like it ...
Theranos founder Elizabeth Holmes began serving an 11-year sentence in a Texas federal prison on Tuesday, completing a dramatic fall for a biotech entrepreneur who once dazzled Silicon Valley with ...
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014.